デコイ・セラピューティクス
Decoy Therapeutics Inc.
Decoy Therapeutics, Inc. is a preclinical-stage biotechnology company that is leveraging machine learning and AI tools alongside high-speed synthesis techniques to rapidly design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs. The company is headquartered in Cambridge, MA.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -4.18 | $0 | -$3M |
| 2025 Q4 | -18.64 | $0 | -$1M |
| 2025 Q3 | -1.81 | $0 | -$2M |
| 2025 Q2 | -6.77 | $0 | -$862,297 |
| 2025 Q1 | -15.41 | $0 | -$1M |
| 2024 Q4 | -15.24 | $0 | -$742,518 |
| 2024 Q3 |
| -11.38 |
| $0 |
| -$1M |
| 2024 Q2 | -35.59 | $0 | -$1M |